Department Of Defense
-
Vanderbilt’s Joint Commissioning Ceremony celebrates Class of 2024 with fanfare and inspiration
The 208th U.S. Army Band Brass Quintet’s festive and rousing performance set the tone for the Vanderbilt University’s annual Joint Commissioning Ceremony on Friday, May 10, where a standing room only crowd of more than 400 gathered to honor 35 ROTC cadets and midshipmen commissioned into the U.S. Army, Navy and Marine Corps. Read MoreJun 4, 2024
-
Tennessee institutions partner to develop dependable AI for national security applications
Vanderbilt University and the Department of Energy’s Oak Ridge National Laboratory announced a partnership to develop training, testing and evaluation methods that will accelerate the Department of Defense’s adoption of AI-based systems in operational environments. Read MoreMay 30, 2024
-
U.S. Senate confirms Schmidt to lead operational testing and evaluation for the Department of Defense
Douglas Schmidt, Cornelius Vanderbilt Professor of Computer Science, has been confirmed to become Director of Operational Test and Evaluation for the Department of Defense following a full vote by the U.S. Senate on Feb. 29, 2024. Read MoreMar 6, 2024
-
Schmidt nominated to be Director of Operational Test and Evaluation for the Department of Defense
President Joe Biden’s nomination of Douglas Schmidt, Cornelius Vanderbilt Professor of Computer Science, to become Director of Operational Test and Evaluation for the Department of Defense was formally submitted to the Senate on Dec. 4, 2023. Read MoreDec 14, 2023
-
Temperature, newts, and a skin-eating fungus
The emergence of pathogenic skin fungi that cause the disease chytridiomycosis is contributing to the global loss of amphibian populations. Read MoreMar 8, 2021
-
Imaging guidance for nerve repair
A noninvasive, quantitative MRI method could be used after surgical repair of traumatic peripheral nerve injury to help clinicians make decisions about whether additional surgical interventions are needed. Read MoreFeb 9, 2021
-
Possible COVID-19 “decoy”
It might be possible to use vesicles carrying the receptor for SARS-CoV-2, the virus that causes COVID-19, to bind the virus and prevent infection. Read MoreOct 15, 2020
-
Antibodies eye Pacific Island “fever”
Vanderbilt Vaccine Center team isolates monoclonal antibodies against the mosquito-borne Ross River virus, which causes rash, fever and debilitating muscle and joint pain lasting three to six months. Read MoreMay 14, 2020
-
New target to stop Ebola
A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members. Read MoreMay 21, 2018
-
Study seeks new ways to detect sensory issues in TBI patients
Vanderbilt researcher Tonia Rex, Ph.D., is accustomed to performing studies in her lab with a goal of translating the findings into better diagnoses and treatment tools for the visually impaired. Read MoreOct 26, 2017
-
Harris honored for support of employees’ military service
Kaye Harris, MSN, R.N., manager of Supplemental Staffing Programs, has received a Patriotic Employer Award from the Employer Support of the Guard and Reserve (ESGR), a program of the Department of Defense. Read MoreJul 27, 2017
-
Genetics of lung cancer survival
Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans. Read MoreJun 29, 2017
-
Blood type link to cancer survival
Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study. Read MoreMay 17, 2017
-
Studies aim to speed, track peripheral nerve recovery
Surgeons have limited tools to successfully repair and track the recovery of peripheral nerves that have been severely damaged as a result of a traumatic injury, but Vanderbilt investigators hope to change this through research studies recently funded with more than $3 million in grants from the Department of Defense and the National Institutes of Health. Read MoreOct 6, 2016
-
New breast cancer driver
Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers. Read MoreAug 26, 2016
-
Breast cancer: finding the smoking gun
A new method developed at Vanderbilt may help “inventory” all tumor-promoting genes. Read MoreJul 20, 2016
-
Drug combos enhance ovarian cancer cell death
Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities. Read MoreAug 11, 2015
-
Neurofibromin fine-tunes bone growth
The protein neurofibromin acts as a brake in a signaling pathway that is important in bone development, Vanderbilt researchers have discovered. Read MoreMay 6, 2015
-
Vanderbilt to study use of plasma on LifeFlight, extends trial to Rutherford County base
Vanderbilt University Medical Center is participating in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital. Randomized patients who are at risk of hemorrhaging could receive… Read MoreFeb 25, 2015
-
Key to prostate cancer resistance
A combination of two types of therapy may be more effective in treating castration-resistant prostate cancer. Read MoreOct 29, 2014